Literature DB >> 12612719

Infection by cytomegalovirus in patients with neonatal cholestasis.

Nara Léia Gelle de Oliveira1, Fernanda Rafful Kanawaty, Sandra Cecilia Botelho Costa, Gabriel Hessel.   

Abstract

BACKGROUND: Neonatal cholestasis syndrome with an intra or extrahepatic origin has been associated to viral infections. The participation of the cytomegalovirus in the etiopathogenesis of neonatal hepatitis has been already known for some time, but only recently there have been indications that this virus may be one of the possible etiological factors for extrahepatic biliary atresia. AIMS: To assess the prevalence of infection by cytomegalovirus in patients with intrahepatic cholestasis and extrahepatic cholestasis. To compare the clinical characteristics of the intrahepatic cholestasis and extrahepatic cholestasis groups with the cytomegalovirus serological results. Patients and Methods - This study consisted of 76 patients with neonatal cholestasis who were admitted between January 1980 and January 1999 when they underwent a cytomegalovirus serologic study using the ELISA method. A case note was kept on each patient with the following data: age of patient at admission, serologic result for cytomegalovirus, history of maternal infection, prematurity, fetal distress, birth weight, ponderal gain, choluria and fecal acholia. The final anatomic diagnosis of cholestasis was based on the results of an abdominal ultrasonography, a liver biopsy and its evolution. The patients were then divided into two groups: group I - intrahepatic cholestasis and group II - extrahepatic cholestasis. Each of these groups were then divided into two subgroups: subgroup A - positive serology (IgM) for cytomegalovirus and subgroup B - negative serology (IgM) for cytomegalovirus.
RESULTS: The frequency of positive serology (IgM) for cytomegalovirus was 29.4% in children with intrahepatic cholestasis and 28.5% in children with extrahepatic cholestasis. In comparison with group IIB, group IIA presented a higher rate of maternal infection history. The patients in group IIA demonstrated a delayed access to the service in comparison with group IA. The groups did not demonstrate any significant differences regarding the onset age of jaundice, choluria and fecal acholia, birth weight and ponderal gain.
CONCLUSIONS: The positive (IgM) seroprevalence for cytomegalovirus in children with intrahepatic cholestasis and extrahepatic cholestasis is high. The history of maternal infection was more common in extrahepatic cholestasis patients with positive serology for cytomegalovirus. There was a delay in the referral of these patients which resulted in a late diagnosis and surgical treatment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12612719     DOI: 10.1590/s0004-28032002000200012

Source DB:  PubMed          Journal:  Arq Gastroenterol        ISSN: 0004-2803


  9 in total

Review 1.  Current state of clinical diagnosis and treatment of infantile cytomegaloviral hepatitis.

Authors:  Hui-min Yan; Xiao-fang Zhen; Jing Shu; Jing Liu
Journal:  Chin J Integr Med       Date:  2010-02-04       Impact factor: 1.978

2.  Cytomegalovirus-specific T-cell reactivity in biliary atresia at the time of diagnosis is associated with deficits in regulatory T cells.

Authors:  Stephen M Brindley; Allison M Lanham; Frederick M Karrer; Rebecca M Tucker; Andrew P Fontenot; Cara L Mack
Journal:  Hepatology       Date:  2012-04       Impact factor: 17.425

3.  Relationship between prognosis of biliary atresia and infection of cytomegalovirus.

Authors:  Chun Shen; Shan Zheng; Wei Wang; Xian-Min Xiao
Journal:  World J Pediatr       Date:  2008-05       Impact factor: 2.764

4.  Laparoscopic finding of a hepatic subcapsular spider-like telangiectasis sign in biliary atresia.

Authors:  Ying Zhou; Meng Jiang; Shao-Tao Tang; Li Yang; Xi Zhang; De-Hua Yang; Meng Xiong; Shuai Li; Guo-Qing Cao; Yong Wang
Journal:  World J Gastroenterol       Date:  2017-10-21       Impact factor: 5.742

5.  Hepatic interferon γ and tumor necrosis factor a expression in infants with neonatal cholestasis and cytomegalovirus infection.

Authors:  Himali Meshram; Shilpa Velhal; Varsha Padwal; Jyoti Sutar; Ravi Kadam; Jacinta Pereira; Gauri Bhonde; Kalyani Karandikar; Vikrant Bhor; Vainav Patel; Naman S Shetty; Ira Shah
Journal:  Clin Exp Hepatol       Date:  2020-12-30

6.  Web-based calculator for biliary atresia screening in neonates and infants with cholestasis.

Authors:  Dongying Zhao; Shengli Gu; Xiaohui Gong; Yahui Li; Xiaoang Sun; Yan Chen; Zhaohui Deng; Yongjun Zhang
Journal:  Transl Pediatr       Date:  2021-02

7.  A Comparative Study Between Cytomegalovirus Immunoglobulin M-Positive and CMV Immunoglobulin M-Negative Biliary Atresia in Infants Attending a Tertiary Care Hospital in Bangladesh.

Authors:  Sharmin Akter; A S M Bazlul Karim; Md Wahiduzzaman Mazumder; Md Rukunuzzaman; Khan Lamia Nahid; Bishnu Pada Dey; Maimuna Sayeed; A Z M Raihanur Rahman; Kaniz Fathema; Mukesh Khadga
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2022-09-05

8.  Immunohistochemical detection of polyductin and co-localization with liver progenitor cell markers during normal and abnormal development of the intrahepatic biliary system and in adult hepatobiliary carcinomas.

Authors:  Livia Dorn; Luís F Menezes; Gregor Mikuz; Herwart F Otto; Luiz F Onuchic; Consolato Sergi
Journal:  J Cell Mol Med       Date:  2008-10-06       Impact factor: 5.310

9.  The molecular and antigenic tissue impact of viral infections on liver transplant patients with neonatal hepatitis.

Authors:  R Yaghobi; B Geramizadeh; S Zamani; M Rahsaz; N Azarpira; M H Karimi; M Ayatolahi; M Hossein Aghdai; S Nikeghbalian; A Bahador; H Salahi; S A Malek-Hosseini
Journal:  Int J Organ Transplant Med       Date:  2011
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.